RNA Editing for Muscular Dystrophy Therapy© 2016, Springer Science+Business Media New York.Due to lack of effective therapies,
muscular Pre- and posttranscriptional genetic information modification in muscular dystrophy treatment groups of genetic pathologies is musculardystrophy, including such diseases as
Duchenne muscular Pre- and posttranscriptional genetic information modification in muscular dystrophy treatment groups of genetic pathologies is musculardystrophy, including such diseases as
Duchenne muscular RNA Editing for Muscular Dystrophy Therapy© 2016, Springer Science+Business Media New York.Due to lack of effective therapies,
muscular RNA Editing for Muscular Dystrophy TherapyDue to lack of effective therapies,
muscular dystrophies became a focus for gene therapy. Multiple
Therapeutic potential of highly functional codon‑optimized microutrophin for muscle‑specific expression of dystrophin (μDys) for
Duchenne muscular dystrophy (DMD), with several drug candidates currently undergoing